News

BioMed SA eyes new road map to greater economic wins

BioMed SA President Ann Stevens (Photo by Lyndsey Johnson) By W. Scott Bailey, San Antonio Business ...

Diabetes, Infectious Diseases Early Focus of San Antonio Biomed Plan

David Holley, Xconomy Texas —  San Antonio — [Updated 12/14/17, 11:54 p.m. See below.] ...

Industry Publications

The Mission

The Mission is published by the University of Texas Health Science Center.

UTSA Discovery

UTSA Discovery is published annually for the Office of the Vice President for Research by the Office ...

News
DPT Laboratories appoints executive to lead R&D
February 22, 2012

By James Aldridge, San Antonio Business Journal

DPT Laboratories has named Kuljit Bhatia the company's new vice president of research and development at the contract development and manufacturing organization.

Bhatia, who has more than 15 years of pharmaceutical experience in drug product development, previously was vice president of research and development and technical operations at Fougera Pharmaceuticals in Long Island, N.Y.

At DPT, Bhatia will lead the research and pharmaceutical development group and oversee DPT's Center of Excellence for Research & Development in San Antonio. R&D activities include pre-formulation and formulation development strategies for the manufacture of topical and liquid pharmaceutical products, analytical development and validation, process optimization and transfer to manufacturing centers.

"Dr. Bhatia brings extensive experience in comprehensive pharmaceutical development services, along with specific expertise in the area of topical pharmaceutical products, which applies directly to the semi-solid and liquid dosage forms that are our focus at DPT," said Paul Johnson, president of DPT. "His broad understanding of the development process will be a critical asset in our efforts to enhance our continuum of services."

DPT Laboratories is based in San Antonio.

 

Stay informed. Subscribe to BioMed SA news alerts.